Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood
Clinical trial NCT01497184 · COMPLETED
Trial details
- NCT number
- NCT01497184
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2021-03-08
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.